Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model
about
Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks(-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (524W91) inhibits hepatitis B virus replication in primary human hepatocytesThe Anti-hepatitis B Virus Activity of Boehmeria nivea Extract in HBV-viremia SCID MiceDose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection.New animal models of hepatitis B and C.Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol.2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivoGeneration of duck hepatitis B virus polymerase mutants through site-directed mutagenesis which demonstrate resistance to lamivudine [(--)-beta-L-2', 3'-dideoxy-3'-thiacytidine] in vitroReview article: Nucleoside analogues for the treatment of chronic hepatitis B.Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus.In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice.Synthesis of 2-bromomethyl-3-hydroxy-2-hydroxymethyl-propyl pyrimidine and theophylline nucleosides under microwave irradiation. Evaluation of their activity against hepatitis B virus.Colorimetric assay system for screening antiviral compounds against hepatitis B virus.Synthesis and antiviral evaluation of novel 2,3-dihydroxypropyl nucleosides from 2- and 4-thiouracils.
P2860
Q28369077-698E746E-40A5-499B-A723-51E732CE5636Q28379181-7CFD600D-AED5-4F01-85EC-BF764031150FQ33823928-6C014C20-F6BC-48A2-B60B-D2EBEB412CB0Q34109170-28B486B5-7062-41FC-9C98-1A7D817C3BF8Q34282823-18AD4354-9654-434D-88B2-6C83E443440AQ35118261-41DA4CC2-82FD-4004-B4D5-6A7A7E2C2A39Q35122499-F9BA35C5-4769-4651-B9D2-896715367468Q35126374-F115E537-9BAF-4165-AC0A-DFB46DF8C817Q35987869-FCCFF887-A515-4E40-8496-96F41A5E6F48Q39779598-4EFA216F-41EE-468A-AF58-194F9FB5FCBDQ39784993-1CE45C37-168C-4AC8-BF6C-44E71A308C86Q40909623-9D22E3A5-821F-44D1-8AAB-C7CE3336D572Q45413504-42CF3AA8-70D1-4437-8E9C-339DFD1B83D4Q45767325-E721D145-F30E-4C76-A783-D7D639CAB19AQ46251518-E20DA32C-288F-447B-98FB-4E083B7D1BEA
P2860
Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Evaluation of the potent anti- ...... osine in a novel in vivo model
@ast
Evaluation of the potent anti- ...... osine in a novel in vivo model
@en
type
label
Evaluation of the potent anti- ...... osine in a novel in vivo model
@ast
Evaluation of the potent anti- ...... osine in a novel in vivo model
@en
prefLabel
Evaluation of the potent anti- ...... osine in a novel in vivo model
@ast
Evaluation of the potent anti- ...... osine in a novel in vivo model
@en
P2093
P2860
P356
P1476
Evaluation of the potent anti- ...... osine in a novel in vivo model
@en
P2093
Condreay LD
Johnson LC
Painter GR
Powdrill TF
Selleseth DW
P2860
P304
P356
10.1128/AAC.38.3.616
P407
P577
1994-03-01T00:00:00Z